FibroGen

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FibroGen and other ETFs, options, and stocks.

About FGEN

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer.

CEO

Thane Wettig

CEOThane Wettig

Employees

486

Employees486

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

1993

Founded1993

Employees

486

Employees486

FGEN Key Statistics

Market cap

44.84M

Market cap44.84M

Price-Earnings ratio

-0.36

Price-Earnings ratio-0.36

Dividend yield

—

Dividend yield—

Average volume

1.40M

Average volume1.40M

High today

$0.4699

High today$0.4699

Low today

$0.3813

Low today$0.3813

Open price

$0.4411

Open price$0.4411

Volume

1.56M

Volume1.56M

52 Week high

$2.80

52 Week high$2.80

52 Week low

$0.18

52 Week low$0.18

FGEN News

TipRanks 11h

FibroGen reports Q4 EPS 18c, consensus (20c)

Reports Q4 Total revenue from continuing operations for the fourth quarter of 2024 was $3.1 M, as compared to $3.6 M for the fourth quarter of 2023..Upon close...